Chong Kun Dang Pharmaceutical Corp.

South Korea’s Chong Kun Dang Pharma produces a broad portfolio of prescription drugs—anti‑hypertension, anti‑lipid, anti‑diabetes, and immunosuppressants—plus OTC medicines, probiotics, Omega‑3 supplements and health drinks, with a strong global export footprint.

Headquarters: South Korea (KOR)

Chong Kun Dang Pharmaceutical Corp. Logo
Company Profile
Traded Instruments
+ Add Instrument 1
Symbol Name Type Exchange Currency ISIN Status Actions
185750 Chong Kun Dang Pharmaceutical Corp.
Cap: 1145.0B
EQUITY KSC KRW KR7185750007 Active
📈
Home Login